IL1B and Alzheimer disease: However, from an anti-inflammatory point of view, this reduction of both IL-1β and IL-6 could explain the hypothesis, proposed by Borokivova46, according to which ACh levels decrease can favor neuroinflammatory events, as observed in Alzheimer disease.